Abstract

Private Sector Strategies to Address High Drug Prices and the Promise of Reference Pricing Programs

Highlights

  • It can take time for employees to respond to market forces, and employers must recognize that the transition could be difficult for some

  • Some patients may not be able to switch to the lower-price medications based on clinical grounds and may face a significant financial burden in a reference pricing situation

  • Employers may be willing to accept this outcome, given the savings opportunities, but it could be mitigated by so-called good soldier provisions that allow beneficiaries who try the lowerprice drug without success to access the higher-price medication without facing the reference pricing charge.[5]

Read more

Summary

Introduction

The results found by Robinson et al[1] demonstrate the potential of private action, but there are a few important issues to consider. In the period immediately after implementation, employee cost sharing increased considerably.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.